Please login to the form below

Not currently logged in
Email:
Password:

Pharmalink appoints Dr Heather Cook and Marek Poszepczynski

Strengthens senior management team

Pharmalink Marek PoszepczynskiPharmalink has bolstered its senior management team with the appointment of Dr Heather Cook and Marek Poszepcynski (pictured).

Dr Cook joins the Swedish specialty pharmaceutical company as director of regulatory affairs from Lundbeck, where she headed up its regulatory development projects department.

Prior to her time with Lundbeck, Dr Cook served at AstraZeneca as its global regulatory affairs director for oncology and a number of other senior roles, including scientific director for neuroscience and infection.

Pharmalink's other senior management appointment is Marek Poszepcynski who takes up the role of director of business development.

He arrives at the company from analysts Handelsbanken, where he covered European and Swedish biotechnology stocks, and before that was vice president of business development at Karolinska Development.

Pharmalink's managing director Johan Häggblad said: "These appointments add significant talent and new experience to Pharmalink's management team as the company continues to drive forward its late stage clinical development programs for Nefecon and Busulipo and actively seeks new product opportunities.

“It is a measure of our reputation that such high caliber executives have joined us and I look forward to working with Heather and Marek through what is an exciting stage of development."

Picture credit: Lenita Gahlin

30th October 2012

From: Sales, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics